Raniska Tablet 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.
MFDS item code 201401871 · Approved 2014.04.17
This product's status changed to Expired on 2024.04.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
This medication is used for various gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective for preventing Mendelson's syndrome before surgery and treating ulcers after surgery. It assists in preventing ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used for improvement of erosions, bleeding, redness, and swelling of gastric mucosa in case of acute exacerbation of acute and chronic gastritis and upper gastrointestinal bleeding, and is effective for relief of symptoms such as excessive gastric acid, heartburn, and regurgitation. Overall, it is used for the improvement of various gastrointestinal related diseases and symptoms.
1. Adults The usual dose is 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by taking 300 mg twice daily, in the morning and at bedtime. The same dosage applies to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID treatment. Healing usually occurs within 4 weeks; for conditions caused by NSAIDs, it usually occurs within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, a maintenance dose of 150 mg once daily at bedtime is recommended. 2) Reflux esophagitis Take 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medicine 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injectable product. Once oral administration is possible, switch to oral treatment with 150 mg of this medicine twice daily. 5) Preanesthetic medication (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Take 150 mg of this medicine once daily at bedtime. 7) Hyperacidity, heartburn, and acid regurgitation: In patients 12 years of age and older, take 75 mg of this medicine orally twice daily (oral solution only). 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to the patient's age and symptoms.
8–18 years: 150 mg per dose (2 mg/kg), up to twice daily
This medication should not be used by patients who have had an allergic reaction to this medication or its components. It should also not be administered to patients with a rare condition called acute porphyria as it may induce seizures. Patients with impaired kidney function may not eliminate this medication efficiently, leading to elevated blood concentrations, and may require dosage reduction or increasing dosing intervals. Patients with liver dysfunction should use this medication with caution, and those with a history of drug allergies should be given it carefully. Regular monitoring is needed for elderly patients or those taking NSAIDs to reduce the risk of side effects. This medication may mask symptoms of gastric cancer, so patients recently showing dyspeptic symptoms, especially those with gastric ulcers or over middle age, should confirm malignancy before using this drug. Patients with Helicobacter pylori infections in gastric or duodenal ulcers should undergo treatment to eliminate the bacteria. Rarely, serious allergic reactions such as anaphylactic shock may occur, requiring immediate discontinuation and medical treatment if abnormal symptoms arise. If symptoms like urticaria, rash, difficulty in breathing, or low blood pressure occur, discontinue the medication and consult a physician immediately. Decreased blood cell counts, impaired liver function, abnormal heart rhythms, digestive symptoms, and neurological symptoms may occur infrequently, necessitating immediate consultation with healthcare providers if symptoms appear. Special care is needed to monitor for confusion or seizures in patients with kidney impairment. Regular blood tests, liver function tests, and kidney function tests should be performed to confirm treatment efficacy and detect any side effects. Elderly patients and those with chronic lung disease or diabetes, as well as those with weakened immune systems, may face a heightened risk of pneumonia while taking this medication. Driving or operating dangerous machinery should be avoided if dizziness or drowsiness occurs during treatment. Co-administration of other medications may affect absorption or metabolism, particularly regarding anticoagulants like warfarin, necessitating close monitoring of coagulation status. Co-administration with high doses of sucralfate may reduce the absorption of this medication, so it is advisable to space the doses two hours apart. Pregnant women or those who may become pregnant should only use this medication when the benefits outweigh the risks as its safety has not been established. Nursing mothers should also be wary since the drug is excreted in breast milk and use should be carefully considered only when necessary. The safety in children has not been sufficiently verified, hence caution is needed. Elderly patients may require adjustments in dosage and timing due to decreased kidney function leading to increased medication concentration. No serious issues have been reported with overdose, though emergency measures such as vomiting or gastric lavage may be necessary, and hemodialysis may be utilized to remove the drug if needed. This medication should be kept out of reach of children and transferring it to other containers may cause deterioration in quality or accidents.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is protected from light as it may degrade if exposed. It is also recommended to keep the medicine at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication safely.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.